Financial analysis

in EUR mn20102009 before restruct.20092008 excl. exceptional items2008200720062005
Income statement
Revenue576.6581.4581.4619.2619.2665.9600.6484.5
Profit from operations (EBIT)84.9141.6128.6149.2132.9216.7204.2162.3
Profit before tax100.4150.3137.3151.2159.4212.0202.8188.4
Profit for the year45.7114.8105.8115.8109.7166.2158.1154.7
Balance sheet
Non-current assets344.4300.0281.6275.1195.8198.1194.3
Current assets426.9422.6446.9422.4460.0306.0321.4
Total assets771.3722.6728.5697.5655.8504.1515.7
Equity attributable to owners of Nobel Biocare320.0317.7318.6267.6267.9360.8357.7
Non-current provisions2.74.00.35.78.915.315.2
Pension liabilities6.22.72.12.11.61.81.5
Convertible bond252.4237.0238.8238.8206.5
Deferred tax liabilities26.427.032.532.57.811.412.2
Other non-current liabilities0.50.58.38.3
Other current liabilities163.1133.7127.9142.5163.1114.8129.1
Total equity and liabilities771.3722.6728.5697.5655.8504.1515.7
Cash and cash equivalents including bank overdraft239.5240.7163.4163.4186.2130.9128.4
Miscellaneous
Net cash from operating activities97.1177.8169.0169.0134.1160.3107.8
Investments in property, plant and equipment23.318.330.430.424.920.019.6
Employees (number)2,4332,2422,5412,5412,2421,9931,648
Key ratios
Revenue growth (%)-0.8-6.1-6.1-7.0–7.010.924.024.7
Gross margin (%)77.780.680.581.179.784.084.082.2
EBITDA margin (%)19.929.126.928.425.835.036.636.1
Operating (EBIT) margin (%)14.724.422.124.121.532.534.033.5
Net profit margin (%)7.919.718.218.717.725.026.331.9
Return on average equity (%)14.238.535.542.341.649.847.042.4
Equity/assets ratio (%)41.545.244.043.838.440.971.669.4
Net debt/equity ratio (%)4.1-0.6-0.620.524.4–16.9–36.9–49.8
Net debt/EBITDA0.12-0.01-0.010.370.41–0.19–0.61–1.02
Interest coverage ratio (times)6.77.78.89.235.069.859.2

 

Give us your feedback!

Summarize your comments
Email